Metraipolis › archive › dc_d9aaecaf3c60

In Silico Evaluation of Paxlovid's Pharmacometrics for SARS-CoV-2: A Multiscale Approach — Europe PMC PMID:35632843

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35632843
DOI
10.3390/v14051103
License (as archived)
solo-consultazione
Archived
2026-10-08T06:53:56.486Z
SHA-256 of the archived text
947c4479f75e17eb5d9601fcbdfa1f758cb47295c87cdbf3dd72d737c8af6a95
Stable URL of this page
https://metraipolis.com/documento/dc_d9aaecaf3c60

How to cite

In Silico Evaluation of Paxlovid's Pharmacometrics for SARS-CoV-2: A Multiscale Approach — Europe PMC PMID:35632843 — Europe PMC (en), https://europepmc.org/article/MED/35632843 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d9aaecaf3c60 (Metraipolis archive dc_d9aaecaf3c60, sha256 947c4479f75e17eb5d9601fcbdfa1f758cb47295c87cdbf3dd72d737c8af6a95)
BibTeX
@misc{dcd9aaecaf3c60,
  title = {In Silico Evaluation of Paxlovid's Pharmacometrics for SARS-CoV-2: A Multiscale Approach — Europe PMC PMID:35632843},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35632843},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d9aaecaf3c60; sha256 947c4479f75e17eb5d9601fcbdfa1f758cb47295c87cdbf3dd72d737c8af6a95},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/35632843. Agents can read the archived copy with the MCP tool read_document.